Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-04-02 Sale | 2026-04-06 4:30 pm | Replimune Group Inc. | REPL | Sarchi Christopher Chief Commercial Officer | 6,500 | $8.01 | $52,065 | 151,588 (Direct) | View |
| 2025-12-09 Sale | 2025-12-11 4:30 pm | Replimune Group Inc. | REPL | Dhingra Kapil Director | 3,169 | $10.4 | $32,958 | 0 (Direct) | View |
| 2025-12-02 Sale | 2025-12-04 4:30 pm | Replimune Group Inc. | REPL | Patel Sushil Chief Executive Officer | 10,000 | $11.13 | $111,300 | 333,576 (Direct) | View |
| 2025-11-17 Sale | 2025-11-19 4:31 pm | Replimune Group Inc. | REPL | Sarchi Christopher Chief Commercial Officer | 5,208 | $9.1 | $47,393 | 123,088 (Direct) | View |
| 2025-11-17 Sale | 2025-11-19 4:30 pm | Replimune Group Inc. | REPL | Xynos Konstantinos Chief Medical Officer | 7,248 | $9.1 | $65,957 | 139,685 (Direct) | View |
| 2025-08-15 Sale | 2025-08-19 8:30 pm | Replimune Group Inc. | REPL | Hill Emily Luisa Chief Financial Officer | 9,154 | $5.37 | $49,157 | 134,368 (Direct) | View |
| 2025-05-20 Sale | 2025-05-22 9:47 pm | Replimune Group Inc. | REPL | Astley-Sparke Philip Director | 32,279 | $8.06 | $260,169 | 1,405,071 (Direct) | View |
| 2025-05-20 Sale | 2025-05-22 9:46 pm | Replimune Group Inc. | REPL | Xynos Konstantinos Chief Medical Officer | 7,952 | $8.06 | $64,093 | 146,933 (Direct) | View |
| 2025-05-20 Sale | 2025-05-22 9:45 pm | Replimune Group Inc. | REPL | Schwendenman Andrew Chief Accounting Officer | 3,287 | $8.05 | $26,460 | 68,284 (Direct) | View |
| 2025-05-20 Sale | 2025-05-22 9:44 pm | Replimune Group Inc. | REPL | Patel Sushil Chief Executive Officer | 25,105 | $8.06 | $202,346 | 343,576 (Direct) | View |
| 2025-05-20 Sale | 2025-05-22 9:44 pm | Replimune Group Inc. | REPL | Hill Emily Luisa Chief Financial Officer | 2,535 | $8.05 | $20,407 | 143,522 (Direct) | View |
| 2025-05-20 Sale | 2025-05-22 9:42 pm | Replimune Group Inc. | REPL | Sarchi Christopher Chief Commercial Officer | 3,749 | $8.05 | $30,179 | 128,296 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-04-01 Option Award | 2026-04-07 9:15 pm | N/A 2036-04-01 | Replimune Group Inc. | REPL | BAKER BROS. ADVISORS LP Baker Bros. Advisors (GP) LLC 667 L.P. Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner | 89,000 | $0 | 89,000 (Indirect) | View |
| 2026-04-01 Option Award | 2026-04-07 9:11 pm | N/A 2036-04-01 | Replimune Group Inc. | REPL | Sarchi Christopher Chief Commercial Officer | 125,000 | $0 | 276,588 (Direct) | View |
| 2026-04-01 Option Award | 2026-04-07 9:10 pm | N/A 2036-04-01 | Replimune Group Inc. | REPL | Astley-Sparke Philip Director | 125,000 | $0 | 1,505,071 (Direct) | View |
| 2026-04-01 Option Award | 2026-04-07 9:10 pm | N/A 2036-04-01 | Replimune Group Inc. | REPL | Oliger Christy J. Director | 44,500 | $0 | 44,500 (Direct) | View |
| 2026-04-01 Option Award | 2026-04-07 9:10 pm | N/A 2036-04-01 | Replimune Group Inc. | REPL | Xynos Konstantinos Chief Medical Officer | 125,000 | $0 | 324,685 (Direct) | View |
| 2026-04-01 Option Award | 2026-04-07 9:09 pm | N/A 2036-04-01 | Replimune Group Inc. | REPL | Balachandran Madhavan Director | 44,500 | $0 | 44,500 (Direct) | View |
| 2026-04-01 Option Award | 2026-04-07 9:09 pm | N/A 2036-04-01 | Replimune Group Inc. | REPL | Schwendenman Andrew Chief Accounting Officer | 91,667 | $0 | 169,951 (Direct) | View |
| 2026-04-01 Option Award | 2026-04-07 9:09 pm | N/A 2036-04-01 | Replimune Group Inc. | REPL | Patel Sushil Chief Executive Officer | 628,100 | $0 | 1,161,676 (Direct) | View |
| 2026-04-01 Option Award | 2026-04-07 9:09 pm | N/A 2036-04-01 | Replimune Group Inc. | REPL | Dhingra Kapil Director | 44,500 | $0 | 44,500 (Direct) | View |
| 2026-04-01 Option Award | 2026-04-07 9:08 pm | N/A 2036-04-01 | Replimune Group Inc. | REPL | Pucci Paolo Director | 44,500 | $0 | 44,500 (Direct) | View |
| 2026-04-01 Option Award | 2026-04-07 9:08 pm | N/A 2036-04-01 | Replimune Group Inc. | REPL | SLATTERY JOSEPH P Director | 44,500 | $0 | 44,500 (Direct) | View |
| 2026-04-01 Option Award | 2026-04-07 9:08 pm | N/A 2036-04-01 | Replimune Group Inc. | REPL | Peeples-Dyer Veleka Director | 44,500 | $0 | 44,500 (Direct) | View |
| 2026-04-01 Option Award | 2026-04-07 9:08 pm | N/A 2036-04-01 | Replimune Group Inc. | REPL | Hill Emily Luisa Chief Financial Officer | 125,000 | $0 | 319,368 (Direct) | View |
| 2026-04-01 Option Award | 2026-04-07 9:07 pm | N/A 2036-04-01 | Replimune Group Inc. | REPL | Weinand Dieter Director | 44,500 | $0 | 44,500 (Direct) | View |
| 2026-02-18 Gift | 2026-02-20 4:15 pm | N/A N/A | Replimune Group Inc. | REPL | Astley-Sparke Philip Director | 25,000 | $0 | 1,380,071 (Direct) | View |
| 2025-12-19 Option Award | 2025-12-19 5:14 pm | N/A N/A | Replimune Group Inc. | REPL | Patel Sushil Chief Executive Officer | 200,000 | $0 | 533,576 (Direct) | View |
| 2025-12-19 Option Award | 2025-12-19 5:13 pm | N/A N/A | Replimune Group Inc. | REPL | Xynos Konstantinos Chief Medical Officer | 60,000 | $0 | 199,685 (Direct) | View |
| 2025-12-19 Option Award | 2025-12-19 5:12 pm | N/A N/A | Replimune Group Inc. | REPL | Hill Emily Luisa Chief Financial Officer | 60,000 | $0 | 194,368 (Direct) | View |
| 2025-12-19 Option Award | 2025-12-19 5:11 pm | N/A N/A | Replimune Group Inc. | REPL | Sarchi Christopher Chief Commercial Officer | 35,000 | $0 | 158,088 (Direct) | View |
| 2025-12-19 Option Award | 2025-12-19 5:10 pm | N/A N/A | Replimune Group Inc. | REPL | Schwendenman Andrew Chief Accounting Officer | 10,000 | $0 | 78,284 (Direct) | View |
| 2025-12-09 Exercise | 2025-12-11 4:30 pm | N/A N/A | Replimune Group Inc. | REPL | Dhingra Kapil Director | 3,169 | $1.75 | 0 (Direct) | View |
| 2025-12-09 Exercise | 2025-12-11 4:30 pm | N/A 2026-01-21 | Replimune Group Inc. | REPL | Dhingra Kapil Director | 3,169 | $0 | 0 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 8:06 pm | N/A 2035-04-01 | Replimune Group Inc. | REPL | Peeples-Dyer Veleka Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 8:06 pm | N/A 2035-04-01 | Replimune Group Inc. | REPL | Patel Sushil Chief Executive Officer | 416,667 | $0 | 618,681 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 8:05 pm | N/A 2035-04-01 | Replimune Group Inc. | REPL | Pucci Paolo Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 8:05 pm | N/A 2035-04-01 | Replimune Group Inc. | REPL | Balachandran Madhavan Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 8:04 pm | N/A 2035-04-01 | Replimune Group Inc. | REPL | Xynos Konstantinos Chief Medical Officer | 112,500 | $0 | 222,385 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 8:03 pm | N/A 2035-04-01 | Replimune Group Inc. | REPL | Dhingra Kapil Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 8:02 pm | N/A 2035-04-01 | Replimune Group Inc. | REPL | SLATTERY JOSEPH P Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 8:02 pm | N/A 2035-04-01 | Replimune Group Inc. | REPL | Hill Emily Luisa Chief Financial Officer | 112,500 | $0 | 213,557 (Direct) | View |